Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 8, 2005, Pages 1623-1628

  McNally, J Scott ^a,b   Saxena, Archana ^a   Cai, Hua ^c   Dikalov, Sergey ^a   Harrison, David G ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Calcium; Hydrogen peroxide; Reactive oxygen species; Vascular endothelium; Xanthine oxidoreductase

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ANTIOXIDANT; CALCIMYCIN; CALCIUM; CALCIUM IONOPHORE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; HYDROGEN PEROXIDE; LINSIDOMINE; MENADIONE; NITRIC OXIDE DONOR; PHOSPHOLIPASE C; REACTIVE OXYGEN METABOLITE; REAGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THAPSIGARGIN; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL CELL; AORTA; ARTICLE; CALCIUM CELL LEVEL; CELL LABELING; CHEMICAL REACTION; CONTROLLED STUDY; COW; CULTURE MEDIUM; ELECTRON SPIN RESONANCE; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME SYNTHESIS; FEEDBACK SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; CALCIMYCIN; CALCIUM; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; HYDROGEN PEROXIDE; IONOPHORES; NITRIC OXIDE; OXIDANTS; PHOSPHOLIPASE C; SUPEROXIDES; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

EID: 23244453929     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000170827.16296.6e     Document Type: Article

References (35)

1. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med. 2002;33:774-797.
2. Kinugasa Y, Ogino K, Furuse Y, Shiomi T, Tsutsui H, Yamamoto T, Igawa O, Hisatome I, Shigemasa C. Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ J. 2003;67:781-787.
3. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106:221-226.
4. Patetsios P, Song M, Shutze WP, Pappas C, Rodino W, Ramirez JA, Panetta TF. Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol. 2001;88:188-191, A186.
5. Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Muller M, Fuchs M, Hilfiker-Kleiner D, Hornig B, Drexler H, Landmesser U. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug? Circulation. 2004;110:2175-2179.
6. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, Drexler H. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation. 2002;106:3073-3078.
7. Waud WR. Rajagopalan KV. The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O). Arch Biochem Biophys. 1976;172:365-379.
8. Rasmussen JT, Rasmussen MS, Petersen TE. Cysteines involved in the interconversion between dehydrogenase and oxidase forms of bovine xanthine oxidoreductase. J Dairy Sci. 2000;83:499-506.
9. Paler-Martinez A, Panus PC, Chumley PH, Ryan U, Hardy MM, Freeman BA. Endogenous xanthine oxidase does not significantly contribute to vascular endothelial production of reactive oxygen species. Arch Biochem Biophys. 1994;311:79-85.
10. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol. 2003;285:H2290-H2297.
11. Beckman JS, Minor RL, Jr., White CW, Repine JE, Rosen GM, Freeman BA. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem. 1988;263:6884-6892.
12. Tong DC, Buck SM, Roberts BR, Klein JD, Tumlin JA. Calcineurin phosphatase activity: activation by glucocorticoids and role of intracellular calcium. Transplantation. 2004;77:259-267.
13. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
14. Fink B, Laude K, McCann L, Doughan A, Harrison DG, Dikalov S. Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am J Physiol Cell Physiol. 2004;287:C895-C902.
15. Volk T, Hensel M, Kox WJ. Transient Ca2+ changes in endothelial cells induced by low doses of reactive oxygen species: role of hydrogen peroxide. Mol Cell Biochem. 1997;171:11-21.
16. Cai H, Li Z, Davis ME, Kanner W, Harrison DG, Dudley SC Jr. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol. 2003;63:325-331.
17. Cai H, Davis ME, Drummond GR, Harrison DG. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol. 2001;21:1571-1576.
18. Niwa K, Inanami O, Ohta T, Ito S, Karino T, Kuwabara M. p38 MAPK and Ca2+ contribute to hydrogen peroxide-induced increase of permeability in vascular endothelial cells but ERK does not. Free Radic Res. 2001;35:519-527.
19. van Gorp RM, Heeneman S, Broers JL, Bronnenberg NM, van Dam-Mieras MC, Heemskerk JW. Glutathione oxidation in calcium- and p38 MAPK-dependent membrane blebbing of endothelial cells. Biochim Biophys Acta. 2002;1591:129-138.
20. Nilius B, Droogmans G, Wondergem R. Transient receptor potential channels in endothelium: solving the calcium entry puzzle? Endothelium. 2003;10:5-15.
21. Dedkova EN, Blatter LA. Nitric oxide inhibits capacitative Ca2+ entry and enhances endoplasmic reticulum Ca2+ uptake in bovine vascular endothelial cells. J Physiol. 2002;539:77-91.
22. Takeuchi K, Watanabe H, Tran QK, Ozeki M, Sumi D, Hayashi T, Iguchi A, Ignarro LJ, Ohashi K, Hayashi H. Nitric oxide: inhibitory effects on endothelial cell calcium signaling, prostaglandin 12 production and nitric oxide synthase expression. Cardiovasc Res. 2004;62:194-201.
23. Sarnesto A, Linder N, Raivio KO. Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein. Lab Invest. 1996;74:48-56.
24. McKelvey TG, Hollwarth ME, Granger DN, Engerson TD, Landler U, Jones HP. Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am J Physiol. 1988;254:G753-G760.
25. McCord JM, Roy RS. The pathophysiology of superoxide: roles in inflammation and ischemia. Can J Physiol Pharmacol. 1982;60:1346-1352.
26. Hirata Y, Ishii K, Taguchi T, Suita S, Takeshige K. Conversion of xanthine dehydrogenase to xanthine oxidase during ischemia of the rat small intestine and the effect of trifluoperazine on the conversion. J Pediatr Surg. 1993;28:597-600.
27. Greene EL, Paller MS. Calcium and free radicals in hypoxia/reoxygenation injury of renal epithelial cells. Am J Physiol. 1994;266:F13-F20.
28. Saksela M, Lapatto R, Raivio KO. Irreversible conversion of xanthine dehydrogenase into xanthine oxidase by a mitochondrial protease. FEBS Lett. 1999;443:117-120.
29. Tokmakov AA, Sato KI, Iwasaki T, Fukami Y. Src kinase induces calcium release in Xenopus egg extracts via PLCgamma and 1P3-dependent mechanism. Cell Calcium. 2002;32:11-20.
30. Thomson L, Trujillo M, Telleri R, Radi R. Kinetics of cytochrome c2+ oxidation by peroxynitrite: implications for Superoxide measurements in nitric oxide-producing biological systems. Arch Biochem Biophys. 1995;319:491-497.
31. O'Donnell VB, Chumley PH, Hogg N, Bloodsworth A, Darley-Usmar VM, Freeman BA. Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochemistry. 1997;36:15216-15223.
32. Ichimori K, Fukahori M, Nakazawa H, Okamoto K, Nishino T. Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide. Nitric oxide converts reduced xanthine-oxidizing enzymes into the desulfo-type inactive form. J Biol Chem. 1999;274:7763-7768.
33. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem. 2003;278:22546-22554.
34. Wei YH. Oxidative stress and mitochondrial DNA mutations in human aging. Proc Soc Exp Biol Med. 1998;217:53-63.
35. Cifuentes ME, Pagano PJ. c-Src and smooth muscle NAD(P)H oxidase: assembling a path to hypertrophy. Arterioscler Thromb Vasc Biol. 2003;23:919-921.